UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the ...
According to the CDC, nearly 100,000 Americans have Sickle Cell Anemia, or 1 in every 265 African American births.
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
BROWARD COUNTY, Fla. — A South Florida family is happy their son no longer lives with chronic pain. Plus, he’s the first in the area to go through FDA-approved gene therapy. Caden Major had been ...
EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- According to the latest findings from Spherix Global Insights’ syndicated Market Dynamix™ service, the US sickle cell disease (SCD) market is approaching a ...
A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers.
Researchers at University College London reported success in treating Huntington's disease with gene therapy, which is the ...